Abstract. Mammalian polo-like kinase 1 (Plkl) is structurally related to the polo gene product of Drosophila melanogaster, Cdc5p of Saccharomyces cerevisiae, and plol ÷ of Schizosaccharornyces pombe, a newly emerging family of serine-threonine kinases implicated in cell cycle regulation. Based on data obtained for its putative homologues in invertebrates and yeasts, human Plkl is suspected to regulate some fundamental aspect(s) of mitosis, but no direct experimental evidence in support of this hypothesis has previously been reported. In this study, we have used a cell duplication, microinjection assay to investigate the in vivo function of Plkl in both immortalized (HeLa) and nonimmortalized (Hs68) human cells. Injection of anti-Plkl antibodies (Plkl +) at various stages of the cell cycle had no effect on the kinetics of DNA replication but severely impaired the ability of cells to divide. Analysis of Plkl +-injected, mitotically arrested HeLa cells by fluorescence microscopy revealed abnormal distributions of condensed chromatin and monoastral microtubule arrays that were nucleated from duplicated but unseparated centrosomes. Most strikingly, centrosomes in Plkl +-injected cells were drastically reduced in size, and the accumulation of both ~/-tubulin and MPM-2 immunoreactivity was impaired. These data indicate that Plkl activity is necessary for the functional maturation of centrosomes in late G2/early prophase and, consequently, for the establishment of a bipolar spindle. Additional roles for Plkl at later stages of mitosis are not excluded, although injection of Plkl + after the completion of spindle formation did not interfere with cytokinesis. Injection of Plkl + into nonimmortalized Hs68 cells produced qualitatively similar phenotypes, but the vast majority of the injected Hs68 cells arrested as single, mononucleated cells in G2. This latter observation hints at the existence, in nonimmortalized cells, of a centrosome-maturation checkpoint sensitive to the impairment of Plkl function.
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C
ELt cycle progression in all eukaryotes depends on the periodic activation and inactivation of cyclindependent kinases (for reviews see Norbury and Nurse, 1992; Morgan, 1995; Nigg, 1995) . However, it is becoming increasingly clear that protein kinases structurally distinct from cyclin-dependent kinases also play important roles in the regulation of cell cycle events. One prominent, newly emerging family of serine/threonine-kinases with a likely role in cell cycle control is represented by the polo gene product of Drosophila melanogaster (Sunkel and Glover, 1988; Llamazares et al., 1991) and its putative homologues Cdc5p of Saccharomyces cerevisiae (Kitada et al., 1993) , plol + of Schizosaccharomyces pombe (Ohkura et al., However, although Sak resembles Drosophila polo over its catalytic domain, it lacks the polo-consensus motif in the carboxy-terminal domain.
The most detailed information about the properties and biological function of polo-like kinases has been obtained for Drosophila polo, the founding member of the family. During Drosophila development, increased levels of polo transcripts are observed in tissues with extensive mitotic activity, and polo protein expression appears to be required for all proliferative stages (Llamazares et al., 1991) . In syncytial embryos, polo kinase activity was reported to peak during late anaphase-telophase (Fenton and Glover, 1993) , and the phenotype of polo mutants strongly suggests a role for this kinase in mitosis (Sunkel and Glover, 1988; Llamazares et al., 1991) . Drosophila mutants homozygous for a strong mutant polo allele (polo 2) die as larvae. However, flies with a weaker mutant allele (polo 2) produce embryos unable to undertake the syncytial mitotic cycles (Sunkel and Glover, 1988) . These embryos display condensed chromosomes associated with branched, highly irregular microtubule arrays, and they appear to lack organized centrosomes (Sunkel and Glover, 1988) . In larval neuroblasts, polo 1 mutants display a range of abnormal mitoses, which include overcondensed and polyploid chromosome complements and monopolar mitotic spindles. During male meiosis, chromosome disjunction is also disturbed (Sunkel and Glover, 1988; Llamazares et al., 1991) .
The putative yeast homologues of polo have also been studied by genetic approaches. In S. cerevisiae, mutations in the CDC5 gene produce abnormalities in both mitotic and meiotic divisions (Hartwell et al., 1973; Byers and Goetsch, 1974; Schild and Byers 1980; Sharon and Simchem, 1990) . CDC5 is essential for viability (Kitada et al., 1993) , and cdc5 mutants arrest in late mitosis as large, budded, dumbbell-shaped cells, with partially segregated nuclei on an elongated spindle (Kitada et al., 1993) . In the case of S. pombe, loss of plol + function has two distinct consequences: it leads to either a mitotic arrest in which condensed chromosomes are associated with a monopolar spindle or, following the completion of nuclear division, to a failure in septation (Ohkura et al., 1995) . Overexpression of wild-type plol ÷ results in the formation of monopolar spindles and multiple septa, and, interestingly, multiple septa are formed even when plol ÷ is overexpressed in Gl-arrested cells (Ohkura et al., 1995) . These results suggest that the fission yeast plol ÷ kinase may play a dual role, being involved in both the establishment of a bipolar spindle and in septum formation.
To what extent Drosophila polo, budding yeast Cdc5p, and fission yeast plol ÷ perform exactly corresponding functions is not clear at this time. Likewise, the biological role of vertebrate Plkl remains to be established, and as yet, information pertaining to mammalian Plkl function is mainly indirect. Plkl transcripts are highly expressed in tissues and cells exhibiting a high mitotic index (Clay et al., 1993; Lake and Jelinek, 1993; Golsteyn et al., 1994; Holtrich et al., 1994) , including tumors and immortalized cell lines (Holtrich et al., 1994) . Similar to budding yeast CDC5 (Kitada et al., 1993) , mammalian Plkl mRNA shows a cell cycle-dependent expression, accumulating to maximal levels during G2 and M phases (Lake and Jelinek, 1993; Lee et al., 1995) . Corresponding cell cycle oscillations have also been observed for the Plkl protein (Golsteyn et al., 1994 (Golsteyn et al., , 1995 Hamanaka et al., 1995; Lee et al., 1995) and Plkl-associated casein kinase activity (Golsteyn et al., 1995; Hamanaka et al., 1995; Lee et al., 1995) . Most interestingly, Plkl associates with the mitotic spindle apparatus throughout mitosis (Golsteyn et al., 1994 (Golsteyn et al., , 1995 Lee et al., 1995) . Specifically, the kinase localizes to spindle poles during prophase and metaphase, redistributes to the spindle equatorial plane (the midzone) as cells enter anaphase, and finally, concentrates at the midbody during telophase (Golsteyn et al., 1994 (Golsteyn et al., , 1995 Lee et al., 1995) .
The data described above support the view that vertebrate Plk may play a role during mitotic progression, much like its purported homologues in lower organisms. However, we emphasize that data on the biological function of mammalian Plkl remain scarce, and there is no direct evidence for a mitotic role. Instead, results obtained with a sense-antisense RNA approach were interpreted to indicate that Plkl functions somehow in the regulation of DNA replication (Hamanaka et al., 1994) . In these experiments, microinjection of in vitro transcribed Plkl sense mRNA into serum-starved murine NIH 3T3 cells was reported to induce DNA synthesis, whereas full-length antisense RNA appeared to block thymidine incorporation in growing cells (Hamanaka et al., 1994) .
The goal of the present study was to directly explore the in vivo function of Plkl in human cells. To this end, highly specific anti-Plkl antibodies were microinjected into both immortalized (Hela) and nonimmortalized (Hs68) human cells at various stages of the cell cycle, and the ability of the injected cells to perform cell cycle functions was monitored. No evidence was obtained to support a role for Plkl in S phase progression. Instead, our data clearly demonstrate that Plkl function is required for both immortalized and nonimmortalized ceils to proceed normally through mitosis. Cells injected with anti-Plkl antibodies displayed striking defects in their ability to assemble a bipolar spindle. As indicated by the use of antibodies against several centrosomal antigens, these defects most probably arise from a failure of centrosomes to undergo critical structural changes at the G2 to M transition. Additional roles for Plkl at later stages of mitosis are not excluded, although they could not be revealed by antibody microinjection. Finally, microinjection of anti-Plkl antibodies into nonimmortalized Hs68 cells revealed that the majority of these cells failed to enter mitosis in the absence of Plkl function. This observation raises the intriguing possibility that the activation of Cdc2 kinase in nonimmortalized cells may depend on Plkl function and/or proper centrosome maturation.
Materials and Methods

Cell Culture, Synchronization, and Extraction
Hs68 human foreskin fibroblasts were obtained from the American Type Culture Collection (Rockville, MD) and grown for not more than eight passages. All cells were cultured in DME (GIBCO BRL, Gaithersburg, MD) supplemented with 5% (HeLa) or 10% (Hs68) FCS and penicillinstreptomycin (100 i.u./ml and 100 p.g/ml, respectively) at 37°C in 7% CO2. G0-arrested Hs68 fibroblasts were obtained by incubating 50% confluent cultures for 36 h in DME without FCS. After this period, <1% of the ceil population incorporated bromodeoxyuridine (BrdU) during an incubation for 24 h, as detected by immunofluorescence microscopy (see below). This result correlated well with cell cycle analysis by flow cytometry, using a FACS II ® fluorescence-activated cell sorter, (Becton-Dickinson Immunocytometry Systems, Mountain View, CA), which demonstrated that >95% of the cells presented a 2 N DNA content. To arrest exponentially growing HeLa cells at prometaphase, nocodazole (Sigma Chemical Co., St. Louis, MO) was added to a final concentration of 50 ng/ml for 17 h. Mitotic cells were collected by mechanical shake-off, rinsed twice in prewarmed medium, and replated in standard HeLa growth medium. To arrest HeLa cells at the G1/S boundary, aphidicolin (1 ~g/ml; Sigma Chemical Co.) was added for 19 h. This treatment resulted in an accumulation of cells that were >80% arrested in late G1/early S phase with a 2 N DNA content, as assessed by flow cytometry.
Cell extracts were prepared in NP-40 lysis buffer (50 mM Tris-HCI, pH 8.0, 120 mM NaCI, 1% NP-40, 20 mM NaF, 1 mM EDTA, 5 mM EGTA, 20 mM [3-glycerol phosphate, 0.1 mM PMSF, 10 I~g/ml leupeptin, 10 ~g/ml pepstatin A, 0.1 mM aprotinin) essentially as outlined in Golsteyn et al. (1995) , except that lysates were centrifuged at 12,000 g (4°C) for 20 min immediately after extraction. Total protein concentrations were determined using the BioRad Protein Assay system (Hercules, CA) and BSA as a calibration standard.
Iramunocheraical Techniques
Anti-Plkl lgG (Plkl ÷) were affinity purified from serum R32 as previously reported (Golsteyn et al., 1995) . A negative control antibody (Plkl-) was prepared by passing the flow through the affinity column, depleted of all Plkl-specific antibodies, over a protein A-Sepharose column (Pharmacia LKB Biotechnology, Piscataway, N J) and eluting with 100 mM glycine-HCI, pH 3.0, according to manufacturers instructions. Purified Plkl ÷ and Plkl-IgG preparations, as well as nonimmune IgG (Sigma Chemical Co.), were dialyzed extensively against PBS, concentrated using a Centricon 30 unit (Amicon, Beverly, MA) and frozen in small aliquots at -70°C. Affinity-purified IgG specific for the human kinesin-related motor protein HsEg5 (Eg5÷; Blangy et al., 1995) was also prepared as above.
For immunoblotting, 10 Ixg of HeLa or Hs68 whole cell extracts or 3 ixg of an extract from Sf9 cells overexpressing recombinant Plkl (see Golsteyn et al., 1995) were resolved on a 10% acrylamide SDS-PAGE gel, transferred to nitrocellulose membranes, and incubated with Plkl + or Plkl-IgG (112 ng/ml in PBS containing 0.5% Tween 20), followed by alkaline phosphatase-conjugated secondary antibodies (1/5,000 in PBS containing 0.5% Tween 20; Promega Corp., Madison, Wl), as previously described (Krek and Nigg, 1991) .
Microinjection and Immunofluorescence Microscopy
For microinjection of asynchronous cells, HeLa and Hs68 cells were grown on acid-washed coverslips until 50% confluent and injected with antibodies using glass capillary needles (Clark Electromedical Instruments, Reading, UK) pulled on a micropipette puller (Flaming/Brown; Sutter Instruments Co., Novato, CA). Alternatively, ceils were injected after serum starvation for 30-36 h (Hs68 GO injections), after a nocodazole block and a 6-8 h release (HeLa G1 injections), or after an aphidicolin block and a 5-6 h release (HeLa late S phase injections). All coverslips were transferred into fresh medium shortly before injection of the appropriate IgG preparation (1.7 and 2 mg/ml for Plkl ÷ and Eg5 ÷ lgG, respectively, in 75% PBS) into the cytoplasm of interphase or metaphase ceils. Injections were either clustered for DNA synthesis experiments or widely scattered (one cell per microscopic field) so that any effects on the ability of injected cells to divide could be clearly observed. After injection, coverslips were placed into fresh medium containing 5% FCS (for HeLa cells), 10% FCS (for Hs68 asynchronous injections), or 20% FCS (for Hs68 GO injections). For measurements of DNA synthesis, bromodeoxyuridine/fluorodeoxyuridine (Amersham Corp., Arlington Heights, IL) was added to the medium (1/1,000) for the duration of the experiment or for the times specified in the text.
Cells were fixed at room temperature for 10 min with 3.7% formaldehyde in PBS and permeabilized for 30 s with 100% acetone at -20°C. Injected cells were located by incubating coverslips with biotinylated antirabbit IgG antibodies (1/50 in PBS containing 1% BSA [PBS/BSA]; Amersham Corp.) for 1 h, followed by a mixture of Texas red-conjugated streptavidin (1/200 in PBS/BSA; Amersham Corp.) and Hoechst 33258 (0.5 p~g/ml in PBS/BSA; Calbiochem-Novabiochem, La Jolla, CA) for 30 min. For analysis of DNA synthesis, fixed and permeabilized cells were treated for 10 min at room temperature with 1.5 M HCI followed by extensive washing with PBS. BrdU incorporation into nuclei was revealed as above, except that an anti-BrdU mouse mAb (Amersham Corp.) was used in the primary incubation, followed by FITC-conjugated anti-mouse lgG antibodies (Sigma Chemical Co.).
For costaining of injected antibodies and microtubules, cells were first incubated with undiluted rat anti-tubulin YOL1/34 hybridoma supernarant (Serotec Ltd., Oxford, UK) for 1 h, followed by biotinylated anti-rat lgG antibodies (1/100 in PBS/BSA; Amersham Corp.) for 30 min and, finally, Texas red-conjugated streptavidin (1/200 in PBS/BSA), Hoechst 33258 (0.5 ~g/ml in PBS/BSA), and FITC-conjugated anti-rabbit IgG antibodies (I/100 in PBS/BSA; Sigma Chemical Co.) for 30 min. For staining of centrosomes with the mouse mAb CTR453, cells were fixed either as above or in -20~C methanol for 6 min, as described previously (Bailly et al., 1989) . For v-tubulin staining, a rat antipeptide polyclonal antibody raised against a synthetic peptide (Joshi et al., 1992) was used, kindly provided by Val Scott and Keith Gull (University of Manchester, UK), and cells were preextracted in detergent and fixed as previously described (MacRae et al., 1990) . Before staining with the MPM-2 mAb, cells were preextracted before methanol fixation, as previously described (Vandr6 et al., 1984) . CTR453, ~/-tubulin, and MPM-2 epitopes were revealed using the tubulin staining protocol, except that either CTR453 (diluted l/5 in PBS/BSA), -/-tubulin (diluted 1/~00 in PBS/BSA), or MPM-2 (diluted 1/ 1,000 in PBS/BSA) antibodies were used for the primary incubation, followed by biotinylated anti-mouse or anti-rat IgG antibodies (1/50 in PBS/ BSA; Amersham Corp.). Coverslips were routinely mounted in 80% glycerol, 3% n-propyl gallate (in PBS), but were mounted in 90% glycerol, I00 mM Tris-HCl, pH 9.0, for DNA synthesis experiments. Cells were observed with a microscope (Axiophot; Carl Zeiss, Inc., Thornwood, NY) using 63 or 100x oil immersion objectives. In some cases, confocal laser scanning microscopy was performed on an invert laser scan microscope (model LSM 410; Carl Zeiss, Inc.), with a 63× plan-APOCHROMAT oil immersion objective, according to manufacturers instructions. Excitation wavelengths used were 488 nm for FITC (argon laser) and 543 nm for Texas red (helium/neon laser), with absorption windows of 510--525 nm and >570 nm, respectively. Confocal images presented in this paper represent projections of Z-series scans.
Results
A Polyclonal Antibody Highly Specific for Plkl in HeLa and Hs68 Cells
A rabbit polyclonal antibody (R32) was raised against the carboxy-terminal 202 amino acids of human Plkl (Golsteyn et al., 1995) . For the purpose of the present microinjection study, Plkl-specific IgG (Plkl +) were affinity purified from R32 serum. As a control, nonspecific IgG (Plkl-) were prepared from the flow through of the affinity column. The specificity of these reagents is demonstrated in Fig. 1 (see also Golsteyn et al., 1995) . Upon immunoblotting, Plkl + decorated a single N66-kD protein in asynchronous HeLa and Hs68 cell extracts (Fig. 1 , lanes 2 and 3). This protein comigrated exactly with recombinant Plkl expressed in baculovirus-infected Sf9 insect cells (lane 1). It is noteworthy that the expression level of Plkl protein was approximately twofold lower in Hs68 than in HeLa cells (compare lanes 2 and 3), probably reflecting the lower mitotic index of nonimmortalized cell populations. Also, no Plkl protein could be detected in extracts derived from G0-arrested Hs68 cells (Jane 4), consistent with previous analyses of Plkl mRNA levels (Lake and Jelinek, 1993; Holtrich et al., 1994; Lee et al., 1995) . The Plkl-IgG did not recognize Plkl in any of the samples (Fig. 1 , lanes 5-7), indicating that this preparation had indeed been successfully depleted of all Plkl-specific antibodies and could thus be used as an innocuous control.
Plkl ÷ InJection Does Not Affect DNA Synthesis in HeLa or Hs68 Cells
On the basis of antisense experiments, Plkl had previously been implicated in the control of D N A replication (Hamanaka et al., 1994) . Therefore, we wished to determine whether microinjection of Plkl-specific antibodies would interfere with D N A synthesis. Equal concentrations of Plkl ÷ and P l k l -IgG (1.7 mg/ml) were injected into the cytoplasm of both asynchronous HeLa and G0-arrested Hs68 cells. Then, BrdU was added to the injected cells, and these were either further cultured for 20 h (HeLa) or released into the cell cycle by readdition of serum for 40 h (Hs68). After fixation, the ability of injected cells to incorporate BrdU into nuclei was assessed using an anti-BrdU m A b for indirect immunofluorescence microscopy. In both cell types, very similar proportions of cells had incorporated BrdU, regardless of whether they had been injected with Plkl ÷ or P l k l -antibodies, or had not been injected at all (Fig. 2 A) .
The above experiment argued that Plkl ÷ antibodies did not block D N A synthesis, but it remained possible that they might have influenced the kinetics of either entry into or exit from S phase. To examine this possibility, both HeLa and Hs68 cells were synchronized before injection with Plkl ÷ antibodies. HeLa cells were arrested in prometaphase with nocodazole and then released and microinjected in the subsequent early G1 phase. Hs68 cells, on the other hand, were arrested in GO by serum starvation and then injected and released into the celt cycle by serum readdition. In both cases, entry into and exit from S phase were monitored by pulse labeling with BrdU. The results, summarized in Fig. 2 B, clearly show that cells microinjected with Plkl ÷ entered and exited S phase with the same kinetics as the surrounding, noninjected cells. We conclude, therefore, that injection of Plkl-specific IgG has no effect on the ability of either HeLa or Hs68 cells to proceed through S phase. These results lend no support to the proposition that Plkl plays a role in S phase events (Hamanaka et al., 1994; see Discussion) . 
Plkl + Injection into HeLa Cells Interferes with Mitotic Progression and Cell Division
During the course of the experiments described above, we had noticed a build-up of rounded, mitotic-like ceils after Plkl + injection. To investigate the possibility that Plkl might be required for progression through mitosis, we established a protocol of scattered microinjection, Accord- been implicated in the control of D N A replication (Hamanaka et al., 1994) . Therefore, we wished to determine whether microinjection of Plkl-specific antibodies would interfere with D N A synthesis. Equal concentrations of Plkl ÷ and P l k l -IgG (1.7 mg/ml) were injected into the cytoplasm of both asynchronous HeLa and G0-arrested Hs68 cells. Then, BrdU was added to the injected cells, and these were either further cultured for 20 h (HeLa) or released into the cell cycle by readdition of serum for 40 h (Hs68). After fixation, the ability of injected cells to incorporate BrdU into nuclei was assessed using an anti-BrdU m A b for indirect immunofluorescence microscopy. In both cell types, very similar proportions of cells had incorporated BrdU, regardless of whether they had been injected with Plkl + or P l k l -antibodies, or had not been injected at all (Fig. 2 A) . The above experiment argued that Plkl ÷ antibodies did not block D N A synthesis, but it remained possible that they might have influenced the kinetics of either entry into or exit from S phase. To examine this possibility, both HeLa and Hs68 cells were synchronized before injection with Plkl ÷ antibodies. HeLa cells were arrested in prometaphase with nocodazole and then released and microinjected in the subsequent early G1 phase. Hs68 cells, on the other hand, were arrested in GO by serum starvation and then injected and released into the celt cycle by serum readdition. In both cases, entry into and exit from S phase were monitored by pulse labeling with BrdU. The results, summarized in Fig. 2 B, clearly show that cells microinjected with Plkl + entered and exited S phase with the same kinetics as the surrounding, noninjected cells. We conclude, therefore, that injection of Plkl-specific IgG has no effect on the ability of either HeLa or Hs68 cells to proceed through S phase. These results lend no support to the proposition that Plkl plays a role in S phase events (Hamanaka et al., 1994; see Discussion) . 
During the course of the experiments described above, we had noticed a build-up of rounded, mitotic-like ceils after Plkl + injection. To investigate the possibility that Plkl might be required for progression through mitosis, we established a protocol of scattered microinjection, AccordThe Iournal of Cell Biology, Volume | 35, 1996 ing to this protocol, only one cell per microscopic field is injected, and the fate of each cell is then monitored as a function of time. In a first series of experiments, Plkl + or control antibodies were microinjected into the cytoplasm of asynchronously growing HeLa cells, and after incubation for 20 or 40 h, cells were analyzed by fluorescence microscopy using secondary antibodies to visualize injected cells and Hoechst dye to monitor the state of the DNA. The results of these experiments are summarized in Fig. 3 and Table I . Of the Plkl--injected cells, >90% proceeded through mitosis to the two cell stage by 20 h, with only very few cells in mitosis (<1%), and with no significant proportion of abnormal phenotypes evident. After 40 h, most of these cells had proceeded through a second round of division, reaching the four cell stage (Fig. 3 A and Table I ). Identical results were obtained after injection of a nonimmune IgG control (Table I ). In contrast, only 30% of the cells injected with Plkl + had divided normally by 20 h, while 34% accumulated as rounded, mitotic-like cells (Table I). Hoechst staining of these cells revealed condensed, ball-like chromosomes that, in most cases, exhibited no obvious alignment in a metaphase plate (Fig. 3 B, a) . Some 25% of the cells displayed additional abnormal phenotypes ( Fig. 3 B and Table I ). These included cells with strikingly fragmented nuclei (referred to as micronuclei; Fig. 3 B, b) or with multiple nuclei of unknown karyotype (Fig. 3 B, c) , and cells that had undergone inappropriate nuclear division, as characterized by the appearance of DNA strands between divided cells (Fig. 3 B, d) . By 40 h after injection of Plkl ÷, the number of abnormal mitotic cells had dropped to 5%, with a concomitant increase in the number of micronucleated and multinucleated cells to 40% (Table I) .
The described phenotypes suggested a function for Plkl specifically during mitosis. One could legitimately argue, however, that Plkl might actually be required earlier in the cell cycle, for example during S phase when centrosomes are duplicated, but that the consequences of impaired Plkl function might only become apparent in the subsequent mitosis. To rule out this possibility, HeLa cells were synchronized at the G1/S border, using aphidicolin, and Plkl ÷ or Plkl-IgG were injected 5-6 h after release from this block, i.e., when cells were in late S phase/early G2 (as assessed by flow cytometry; data not shown). After an additional incubation for 7, 14, or 24 h, cells were fixed and their mitotic index and ability to divide recorded (Fig. 4) . By 13 h after the release from the G1/S block, the time at which we found the wave of mitotic cells to reach its highest level in the control samples, 23 and 19% of noninjected and Plkl--injected cells, respectively, were in mitosis (Fig. 4 A) . At this early time, the number of Plkt + cells in mitosis was somewhat reduced (14%; Fig. 4 A) , and comparatively few of the injected ceils had completed division (19% for Plkl-and 12% for Plkl+; Fig. 4 B) . The impairment of Plkl function did, however, produce striking effects by 20 h; at this time, 77% of Plkl--injected cells had divided (Fig. 4 B) , and, concomitantly, the mitotic index of these as well as the surrounding noninjected cells was strongly reduced (Fig. 4 A) . In marked contrast, comparatively few of the Plkl+-injected cells (26%) had completed division (Fig. 4 B) , and instead, many (45%) had accumulated as rounded, mitotic-like cells (Fig. 4 A) . After 30 h, virtually all Ptkl--injected cells had completed division (87%), but there was no significant further increase in the number of Plkl+-injected cells that had divided (29%; Fig. 4 B) . At this late time, up to 50% of the Plkl +-injected cells were either micronucleated or multinucleated (data not shown). From the data shown in this section, we conclude that abrogation of Plkl function in HeLa cells results in a strong inhibition of progression through mitosis, which ultimately culminates in a lack of cytokinesis and a failure to segregate chromosomes correctly.
Microinjection of Plkl + into HeLa Cells Leads to Nucleation of Abnormal Microtubule Arrays from Small, Duplicated but Unseparated Centrosomes
As a first step towards understanding the molecular basis for the observed requirement for Plkl function during mitosis, Plkl+-injected, mitotically blocked cells (of the type shown in Fig. 3 B, a) were analyzed by confocal and conventional microscopy, using antitubulin and antipericentrosomal mAbs for immunofluorescent staining (Fig. 5) . Whereas Plkl--injected cells were able to set up a normal bipolar spindle (Fig. 5 A, left) , most of the Plkl+-injected cells failed to do so. Instead, 68% of all mitotic cells examined displayed arrays of comparatively thin microtubule bundles nucleating from a single organizing center, more reminiscent of interphase microtubules than of spindle fibres ( Fig. 5 A, right) . Structures resembling bipolar spindles could be observed in the remaining cells, but only few of these looked completely normal (data not shown).
Colocalization of microtubules and the CTR453 antigen, a pericentrosomal protein (Bailly et al., 1989) , revealed that the monoastral microtubule arrays frequently contained two centrosomes that had clearly duplicated but had failed to separate sufficiently for bipolar spindle formation (Fig.   5 B, left) . At first glance, this phenotype appears similar to that previously observed after microinjection of antibodies against HsEg5, a centrosome-associated, kinesin-related motor protein (Blangy et al., 1995) . However, although centrosome separation was indeed inhibited in both cases, a direct comparison of the phenotypes induced by Plkl ÷ or anti-HsEg5 antibodies (Eg5 ÷) revealed striking differences: compared to Eg5+-injected cells, Plkl+-injected cells displayed much smaller centrosomes, and the density of microtubules nucleating from these centrosomes appeared to be decreased (Fig 5 B, compare left and right) .
To confirm the apparent reduction in centrosome size, HeLa cells were injected in the exact same experiment with Plkl ÷ or Eg5 ÷ IgG's. After 20 h, centrosomes were stained with CTR453 and the sizes of centrosomes were recorded using conventional ~ fluorescence microscopy and identical photographic conditions. As can be seen from These data indicate that Plkl function is required for centrosomes to undergo a functional maturation that is typically reflected by an apparent increase in centrosome size (Vorobjev and Nadehzdina, 1987; Kimble and Kuriyama, 1992; Kalt and Schliwa, 1993) . Asynchronously growing interphase HeLa cells were microinjected with Plk 1 +, Plkl , or nonimmune IgG. After 20 and 40 h incubation, cells were fixed and analyzed by immunofluorescence microscopy. Microscopic scanning of the glass coverslip allowed the calculation of the percentage of injected cells with the phenotypes listed. The total results of four independent experiments with the appropriate controls are shown. * MitoUc cells injected with Plkl + display abnormal DNA condensation as described in the text (see also Fig. 3 B, a) . Total number of cells displaying phenotype/total number of injected cells. ~Cells that have gone through at least one normal cell division. For simplicity, ceils that have divided once or twice are grouped together. In contro[-injeeted cells, at least 80% have gone to the four ceil stage.
Plkl + Injection Inhibits the Recruitment of y-Tubulin and MPM-2 Epitopes to Mitotic Centrosomes
To analyze the centrosome maturation defect in more detail, HeLa cells were injected with either Plkl + or Eg5 + IgG's and 20 h later were stained with antibodies recognizing either "y-tubulin (Fig. 6 A) or the MFM-2 phosphoepitope (Fig. 6 B) . ~/-Tubulin is a highly conserved centrosomal protein required for microtubule nucleation (Oakley and Oakley, 1989; Oakley et al., 1990; Steams et al., 1991; Zheng et al., 1991 , Joshi et al., 1992 F61ix et al., 1994; Stearns and Kirschner, 1994; Shu and Joshi, 1995; Sunkel et al., 1995; Moritz et al., 1995a,b) , whereas MPM-2 immunoreactivity appears on multiple proteins upon entry of cells into mitosis (Davis et al., 1983; Vandr6 et al., 1991) , most prominently on mitotic spindle poles (Vandr6 et al., 1984 (Vandr6 et al., , 1986 (Vandr6 et al., , 1991 . Thus, in HeLa cells the accumulation of both -y-tubulin and MPM-2 immunoreactivity can be considered as excellent markers for the functional maturation of centrosomes at the G2 to M transition.
In line with previous results (Zheng et al., 1991; LajoieMazenc et al., 1994) , we found that centrosome staining with anti-'y-tubulin antibodies was comparatively weak in interphase HeLa cells, but increased substantially as cells entered mitosis (Fig. 6 A, compare left panels) . Within monoastral spindles of Plkl+-injected cells, the centrosomes displayed very weak "¥-tubulin staining, reminiscent of interphase cells, whereas in Eg5 + injected mitotic cells, staining was as intense as in noninjected mitotic cells (Fig 6 A, compare right panels) . Although the lack of immunoreactivity cannot be considered as rigorous proof for the absence of the corresponding antigen, the most likely interpretation of these results is that, during the G2 to M transition, Plkl + antibodies specifically inhibited the recruitment of ~/-tubulin to centrosomes, whereas Eg5 + antibodies were without effect. Next, we investigated whether the injection of Plkl +, or Eg5 + for control, would interfere with the appearance of MPM-2 reactivity. 20 h after injection, HeLa cells were stained with MPM-2 (Fig. 6 B , upper) and, for comparison, with antibodies against et-tubulin (Fig. 6 B, lower) . In agreement with previous results (Vandr6 et al., 1984 (Vandr6 et al., , 1986 (Vandr6 et al., , 1991 , the MPM-2 antibody stained spindle poles and spindle microtubules in HeLa cells; in addition, it stained a number of dots in the spindle mid-zone, most likely representing kinetochores (Fig. 6 B, upper left). After injection of Plkl + antibodies, however, MPM-2 reactivity was rearranged. Most typically, spindle poles showed little if any staining, and instead, MPM-2 reactivity was confined to surrounding microtubules (Fig. 6  B, upper middle) . In contrast, MPM-2 reactivity could readily be discerned on the duplicated centrosomes as well as on the astral microtubules in Eg5+-injected cells (Fig. 6  B, upper right) . We reproducibly observed also that kinetochore staining by MPM-2 antibodies was impaired after the microinjection of Plkl + but not Eg5 + antibodies, although this result is very difficult to document photographically (see Fig. 6 B) . These latter data indicate that the accumulation of MPM-2 reactivity at centrosomes, and possibly at kinetochores, is inhibited by Plkl + but not Eg5 + antibodies.
Plkl + Injection Blocks Entry into Mitosis in Noniramortalized Hs68 Fibroblasts
As many immortalized tumor cell lines, including HeLa, are known to be defective in cell cycle checkpoint functions (Hartwell and Weinert, 1989; Murray, 1992; Hartwell and Kastan, 1994) , we considered it important to extend our studies to diploid, nonimmortalized human cells. Specifically, we examined the effects of Plkl + injection on the cell cycle progression of human foreskin fibroblasts (Hs68). Plkl + and Plkl-IgG were injected into the cytoplasm of widely scattered, asynchronously growing interphase Hs68 cells, and 36 or 48 h later, cells were fixed and examined Time of Release (hours) Figure 4 . Plkl ÷ injection of HeLa cells in late S phase inhibits mitotic progression. HeLa cells, synchronized at G1/S by aphidicolin treatment, were released into the cell cycle for 5-6 h before Plkl ÷ or Plkl-injection into the cytoplasm; at that time, they were in late S/early G2 phase. Injections were scattered for accurate counting, and upon continued incubation, cells were fixed and analyzed by immunofluorescence microscopy at the times (post G1/S release) indicated. Indicated are in (A) the mitotic index (i.e., the percentage of cells showing chromosome condensation) and in (B) the percentage of injected cells that had proceeded through one cell division. At least 30 cells were injected for each time point in each experiment, and the averages of three independent experiments with standard deviations are shown.
microscopically. Whereas 52 and 67% of the Plkl--injected cells had divided normally after 36 and 48 h, respectively, with no abnormal phenotypes evident, only 5% of the Plkl+-injected cells had progressed to the two cell stage by these times (Table II) . Furthermore, only 16% of the Plkl+-injected cells had accumulated as rounded, mitoticlike cells by 36 h (Table II) . These abnormal cells displayed the same ball-like chromatin condensation as seen with HeLa cells (Fig. 7 A, right) . Further analysis of these cells by immunofluorescence and confocal microscopy demonstrated a complete absence of bipolar mitotic spindles ( Fig. 7 A, left) . Centrosomes, although duplicated, were unseparated and drastically reduced in size, as described above for HeLa cells (data not shown). By 48 h, the number of mitotically blocked cells decreased to 2%, with a concomitant increase in the proportion of microand multinucleated cells (from 8 to 18% ; Table II) , consistent with the idea that these late phenotypes may represent the end result of aborted mitoses. These results show that Plkl + antibody injection into Hs68 cells could produce aberrant mitotic phenotypes that were qualitatively similar to those observed in HeLa cells. Rather unexpectedly, however, we found that the vast majority of the Plkl+-injected Hs68 cells (75%) persisted as single, interphase cells with apparently normal interphase microtubule networks. As shown in Fig. 7 B, (Tables I and II) . One intriguing interpretation of these results is that nonimmortalized cells contain a checkpoint monitoring the proper maturation of centrosomes (see Discussion).
Plkl ÷ Injection Does Not Affect Mitotic Events Subsequent to Bipolar Spindle Formation
In a final series of experiments, we asked whether Plkl function might also be essential during later stages of mitosis, particularly during cytokinesis. To this end, Plkl + and Plkl-IgG were injected into cells that had already established a mitotic spindle. These were selected amongst exponentially growing HeLa and Hs68 cells, using phase contrast microscopy to identify cells with clearly visible metaphase chromosomes. After 15-20 h, 87 and 97% of control-injected HeLa and Hs68 cells had completed cytokinesis and proceeded to the two-cell stage, respectively (Table III) . Remarkably, a similar percentage of Plkl +-injected cells (88 and 91% of HeLa and Hs68, respectively) had also divided, with no significant percentages of cells displaying abnormal phenotypes (Table III) . These results indicate that Plkl function is no longer sensitive to inhibition by microinjected antibodies beyond the metaphase state. They do not prove that Plkl is not involved in later stages of mitosis (see Discussion), but they provide an exquisite control and attest to the specificity of the block to mitotic progression observed after antibody injection into interphase cells.
Discussion
In this study, we have explored the function of human Plkl, using highly specific anti-Plkl antibodies for microinjection experiments. We have obtained no evidence to support a role for Plkl during D N A replication. Instead, our data clearly establish that Plkl function is required for progression through mitosis. A detailed analysis of the phenotypes of antibody-injected cells indicates that mammalian Plkl is required for the functional maturation of centrosomes, and hence for the assembly of a bipolar spinThe Journal of Cell Biology. Volume 135, 1996 1708 Figure 4 . Plkl ÷ injection of HeLa cells in late S phase inhibits mitotic progressiorL HeLa cells, synchronized at G1/S by aphidicolin treatment, were released into the cell cycle for 5-6 h before Plkl ÷ or Plkl-injection into the cytoplasm; at that time, they were in late S/early G2 phase. Injections were scattered for accurate counting, and upon continued incubation, cells were fixed and analyzed by immunofluorescence microscopy at the times (post G1/S release) indicated. Indicated are in (A) the mitotic index (i.e., the percentage of cells showing chromosome condensation) and in (B) the percentage of injected cells that had proceeded through one cell division. At least 30 cells were injected for each time point in each experiment, and the averages of three independent experiments with standard deviations are shown.
microscopically. Whereas 52 and 67% of the Plkl--injected cells had divided normally after 36 and 48 h, respectively, with no abnormal phenotypes evident, only 5% of the Plkl+-injected cells had progressed to the two cell stage by these times (Table II) . Furthermore, only 16% of the Plkl+-injected cells had accumulated as rounded, mitoticlike cells by 36 h (Table II) . These abnormal cells displayed the same ball-like chromatin condensation as seen with HeLa cells (Fig. 7 A, right) . Further analysis of these cells by immunofluorescence and confocal microscopy demonstrated a complete absence of bipolar mitotic spindles ( Fig. 7 A, left) . Centrosomes, although duplicated, were unseparated and drastically reduced in size, as described above for HeLa cells (data not shown). By 48 h, the number of mitotically blocked cells decreased to 2%, with a concomitant increase in the proportion of microand multinucleated cells (from 8 to 18% ; Table II) , consistent with the idea that these late phenotypes may represent the end result of aborted mitoses. These results show that Plkl + antibody injection into Hs68 cells could produce aberrant mitotic phenotypes that were qualitatively similar to those observed in HeLa cells. Rather unexpectedly, however, we found that the vast majority of the Plkl+-injected Hs68 cells (75%) persisted as single, interphase cells with apparently normal interphase microtubule networks. As shown in Fig. 7 B, these Plkl +-injected cells displayed duplicated centrosomes (middle), the sizes of which were comparable to those of uninjected interphase cells (left), but significantly smaller than those of mitotic cells (right). It would seem, therefore, that most of the Plkl+-injected Hs68 cells did not even attempt entering mitosis, but instead arrested in late interphase. In comparison, only 32% of Plkl--injected Hs68 cells, and only 1% of Plkl+-injected HeLa cells, persisted as single cells (Tables I and II) . One intriguing interpretation of these results is that nonimmortalized cells contain a checkpoint monitoring the proper maturation of centrosomes (see Discussion).
Plkl ÷ Injection Does Not Affect Mitotic Events Subsequent to Bipolar Spindle Formation
Discussion
In this study, we have explored the function of human Plkl, using highly specific anti-Plkl antibodies for microinjection experiments. We have obtained no evidence to support a role for Plkl during D N A replication. Instead, our data clearly establish that Plkl function is required for progression through mitosis. A detailed analysis of the phenotypes of antibody-injected cells indicates that mammalian Plkl is required for the functional maturation of centrosomes, and hence for the assembly of a bipolar spin- die. Additional functions at later stages of mitosis are not excluded. We also found that Plkl+-induced inhibition of cell cycle progression is more pronounced in diploid, nonimmortalized cells (Hs68) than in karyotypically abnormal carcinoma cells (HeLa). Thus, nonimmortalized cells may depend on Plkl function and/or may monitor the proper maturation of centrosomes, before entering mitosis. This G2 checkpoint appears to be lost in at least some immortalized cell lines.
Plkl is Specifically Required for Entry into Mitosis
We found that microinjection of anti-Plkl antibodies resulted in a significant accumulation of abnormal mitotic cells and in a severe block to cell division. Many injected cells displayed ball-like, condensed chromatin and monoastral microtubule arrays reminiscent of interphase microtubules. These were nucleated from a single organizing center that contained duplicated but small, unseparated centrosOmes. At later times after injection of Plkl ÷ antibodies, we also observed an accumulation of multinucleated and micronucleated cells. These phenotypes may represent end products of aborted mitoses. Alternatively, they might reflect additional requirements for Plkl function during later stages of cell division. Antibody injection had no effect on the kinetics of either entry into S phase or exit from S phase. Although negative results need to be interpreted with caution, these data lend no support to a previous study attributing to Plkl an important S phase function (Hamanaka et al., 1994) . Considering our present data, together with the timing of cell cycle-dependent expression and activation of Plkl (Lake and Jelinek, 1993; Golsteyn et al., 1994 Golsteyn et al., , 1995 Lee et al., 1995; Hamanaka et al., 1995) , it appears unlikely that Plkl should perform a ma- jor function during S phase. This does not exclude, however, that other polo-like kinases, such as Snk or Fnk, might play important roles during G1, the G1/S transition, or S phase (Simmons et al., 1993; Donohue et al., 1995) .
Although it is difficult to directly compare the phenotypes produced by Plkl ÷ antibody injection to those resuiting from mutations of the putative Plkl homologues in Drosophila and yeasts (for references see Introduction), our present data fall in line with some of the phenotypes observed for the polo 1 mutant of Drosophila and for plol ÷ gene disruptants in fission yeast. In contrast, cdc5 mutants of budding yeast arrest in late nuclear division with separated chromosomes and thus appear to retain the ability to construct a bipolar spindle. Considering the differences in the temporal and spatial choreography of mitotic events in the above organisms, it is not entirely unexpected that the inhibition of polo homologues may produce distinct phenotypic consequences in different species. Also, we emphasize that our data do not necessarily exclude additional functions for mammalian Plkl at later stages of mitotic progression. Both HeLa and Hs68 cells divided normally when Plkl ÷ antibodies were injected during metaphase, but, considering the rapidity with which mitosis proceeds, it remains possible that antibodies injected during metaphase might not have reached their epitopes in time. Also, Plkl function may be redundant at later stages of mitosis.
Plk l Is Required for the Functional Maturation of Centrosomes and Bipolar Spindle Formation
The centrosomal and spindle abnormalities observed after Plkl ÷ injection strongly suggest a specific role for human Plkl in the establishment of a bipolar spindle. Normally, centrosomes increase in size shortly before the onset of mitosis, and concomitantly, they acquire the ability to nucleate highly dynamic spindle microtubules (Vorobjev and Nadehzdina, 1987; Karsenti, 1991; Kimble and Kuriyama, 1992) . This increase in size is thought to reflect a functional maturation of centrosomes that can be visualized by monitoring the accumulation of multiple proteins (Kalt and Schliwa, 1993; Kellogg et al., 1994; Lange and Gull, 1995) . In HeLa cells, these include -y-tubulin (Zheng et al., 1991; Lajoie-Mazenc et al., 1994) and MPM-2 reactive phosphoepitopes (Vandr6 et al., 1986) . As shown by immunofluorescent staining with several antibodies, the centrosomes in Plkl+-injected cells were much smaller than normal mitotic spindle poles, and furthermore, contained reduced amounts of ~/-tubulin and MPM-2 immunoreactivity, two markers for HeLa mitotic centrosomes. Attesting to the specificity of the observed effects, no changes in Asynchronously growing interphase Hs68 cells were microinjected with Plkl ÷ or Plkl IgG. At the times specified, cells were fixed and analyzed by immunofluorescence microscopy, The coverslip was scanned as in Table I , and scored for cells with the listed phenotypes. The total results from four independent experiments are shown. * Mitotic cells injected with Plk 1 + display abnormal DNA condensation as described in the text (see also Fig. 7 A) . *Total number of cells displaying phenotype/total number of injected cells. ~Cells that have gone through at least one normal cell division.
either centrosome size or marker acquisition were seen in monoastral microtubule arrays produced by the injection of antibodies against HsEg5, a human kinesin-related motor protein (Blangy et al., 1995) . These findings place Plkl upstream of HsEg5, and they imply that Plkl functions before prometaphase, when HsEg5 (and its homologues) act to promote the migration of centrosomes (for review see Sawin and Endow, 1993 ; see also Heck et al., 1993; Blangy et al., 1995) . Furthermore, they indicate that one of the early functions of Plkl concerns the recruitment of specific proteins to centrosomes. In line with this conclusion, it has previously been reported that the centrosomal antigen CP190 (formerly called Bx63) is not recruited to centrosomes in polo l mutant Drosophila embryos (Sunkel and Glover, 1988) . During late G2/early prophase, the microtubule nucleation capacity of centrosomes increases drastically (Snyder and Mclntosh, 1975; Borisy, 1981, Karsenti, 1991) . The cell cycle regulation of this change in centrosomal activity remains poorly understood, but recent studies strongly implicate ~t-tubulin as a critical element in centrosomal microtubule nucleation (Joshi et al., 1992; Frlix et al., 1994; Stearns and Kirschner, 1994; Shu and Joshi, 1995; Sunkel et al., 1995; Moritz et al. 1995a,b) . Our finding that anti-Plkl antibodies inhibit the recruitment of 3,-tubulin to centrosomes raises the possibility that Plkl may participate in promoting the increased centrosomal nucleation activity at the G2 to M transition. This notion is supported by the relatively low density of microtubules in the monoasters of Plkl÷-injected cells (Fig. 5) , and the apparent absence of centrosomal MPM-2 phosphoepitope reactivity in these structures (Fig. 6 B) . MPM-2 reactive phosphoproteins have been found at mitotically activated microtubule organizing centers of all eukaryotic cell types examined (e.g., Vandr6 et al., 1984 Vandr6 et al., , 1986 Vandr6 et al., , 1991 , and dephosphorylation of MPM-2 reactive centrosomal components directly blocks microtubule nucleation in vitro (Centonze and Borisy, 1990) .
Our data raise the possibility that Plkl may itself be an MPM-2 kinase. Alternatively, one or several distinct MPM-2 kinase(s) may depend on Plkl for their activity. In direct support of the former interpretation, a putative Plkl homologue from Xenopus eggs was recently shown to be able to phosphorylate the Cdc25 phosphatase, thereby generating MPM-2 reactive sites and stimulating Cdc25 phosphatase activity (Kumagai and Dunphy, 1996) . Considering that Cdc25C phosphatase is a key activator of Cdc2, these findings have two important implications for the interpretation of our results: firstly, they bear directly on our finding that anti-Plkl antibodies inhibit entry into mitosis in nonimmortalized Hs68 ceils (see below). Secondly, they raise the possibility that Plkl might in part regulate centrosomal structure and nucleation activity through the activation of Cdc25 phosphatase, and consequently, Cdc2 kinase. In support of this view, there is compelling evidence that Cdc2 kinase plays an important role in the activation of centrosomal microtubule nucleation (Buendia 
A Checkpoint Monitoring Centrosome Maturation ?
In an elegant study, microsurgical removal of centrosomes from cultured mammalian cells was shown to prevent all aspects of mitosis, including the activation of Cdc2 kinase (Maniotis and Schliwa, 1991) . This observation strongly suggested a link between centrosomes and Cdc2 activation, but the nature of this link remained unknown (for discussion see Bailly and Bornens, 1992) . A priori, centrosomes might exert control over Cdc2 via a positive signal (emitted by mature centrosomes), via a negative signal (emitted by immature centrosomes), or both. The data by Maniotis and Schliwa (1991) argue in favor of a positive signal, but do not exclude the existence of inhibitory signals. A rote of Plkl in stimulating the Cdc25 phosphatase has recently been established (Kumagai and Dunphy, 1996) , and a possible role for this kinase in counteracting inhibitory pathways involving Wee1 and/or Mytl kinase is worth investigating. Most intriguingly, we have shown here that nonimmortalized diploid fibroblasts (Hs68) respond to the inhibition of Plkl function by a G2 arrest. In contrast, karyotypicalIy abormal cells (HeLa) attempt to proceed through mitosis despite the loss of Plkl function, indicating that they do not depend on Plkl for the activation of Cdc2. Such a scenario appears plausible, since tumor cells frequently display deregulated expression of cell cycle regulators, including Cdc25 (Hunter and Pines, 1994; Galaktionov et at., 1995). Thus, we propose that normal cells may exhibit a checkpoint that causes a G2 arrest in response to the lack of Plkl function and/or the resulting lack of functionally mature mitotic centrosomes. This centrosome maturation-related checkpoint would appear to be absent from HeLa cells. Loss of such a checkpoint might be common among tumor ceils and conceivably contribute to the development of aneuploidies (Murray, 1992; Hartwell and Kastan, 1994) .
